Evidence map›Paper›PMID 32438719›Full record

Trial reportNutrients2020

Effect of a Combination of Citrus Flavones and Flavanones and Olive Polyphenols for the Reduction of Cardiovascular Disease Risk: An Exploratory Randomized, Double-Blind, Placebo-Controlled Study in Healthy Subjects.

Maravillas Sánchez Macarro, Juan Pablo Martínez Rodríguez, Enrique Bernal Morell, Silvia Pérez-Piñero, Desirée Victoria-Montesinos, Ana María García-Muñoz, Fernando Cánovas García, Julián Castillo Sánchez, Francisco Javier López-Román

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Maravillas Sánchez MacarroHealth Sciences Department, Universidad Católica San Antonio de Murcia (UCAM), Campus de los Jerónimos, E-30107 Murcia, Spain.ORCID 0000-0001-7589-1344
Juan Pablo Martínez RodríguezHealth Sciences Ph.D. Program, Universidad Católica San Antonio de Murcia (UCAM), Campus de los Jerónimos, E-30107 Murcia, Spain.
Enrique Bernal MorellUnidad de Enfermedades Infecciosas, Hospital General Universitario Reina Sofia, E-30003 Murcia, Spain.
Silvia Pérez-PiñeroHealth Sciences Department, Universidad Católica San Antonio de Murcia (UCAM), Campus de los Jerónimos, E-30107 Murcia, Spain.
Desirée Victoria-MontesinosHealth Sciences Department, Universidad Católica San Antonio de Murcia (UCAM), Campus de los Jerónimos, E-30107 Murcia, Spain.ORCID 0000-0003-3968-9477
Ana María García-MuñozHealth Sciences Department, Universidad Católica San Antonio de Murcia (UCAM), Campus de los Jerónimos, E-30107 Murcia, Spain.
Fernando Cánovas GarcíaHealth Sciences Department, Universidad Católica San Antonio de Murcia (UCAM), Campus de los Jerónimos, E-30107 Murcia, Spain.ORCID 0000-0002-8837-1927
Julián Castillo SánchezResearch and Development Department, Nutrafur iff-Health, E-30820 Murcia, Spain.
Francisco Javier López-RománHealth Sciences Department, Universidad Católica San Antonio de Murcia (UCAM), Campus de los Jerónimos, E-30107 Murcia, Spain.ORCID 0000-0002-2841-5502
Universidad Católica de Murcia · ESHospital Reina Sofía de Murcia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A single-center, randomized, double-blind controlled trial was conducted to assess the efficacy of a food supplement based on a combination of grapefruit, bitter orange, and olive extracts administered for eight weeks (n = 51) versus placebo (n = 45) on reduction of cardiovascular risk in healthy volunteers. Study variables included flow-mediated vasodilation (FMD), blood pressure (BP), lipid profile, thrombotic status, oxidative stress biomarkers, inflammation-related biomarkers, anthropometric variables, quality of life, and physical activity. The per-protocol data set was analyzed. In the active product group, there were statistically significant within-group differences at eight weeks as compared with baseline in FMD, systolic and diastolic BP, total cholesterol, LDL-C, LDL-oxidase, oxidized/reduced glutathione ratio, protein carbonyl, and IL-6. Significant between-group differences in these variables were also found. Significant changes in anthropometric variables and quality of life were not observed in the study groups. Changes in the level of physical activity were not recorded. Treatment with the active product was well tolerated. All these findings, taken together, support a beneficial effect of supplementation with a mixture of grapefruit, bitter orange fruits, and olive leaf extracts on underlying mechanisms that may interact each other to decrease the cardiovascular risk in healthy people.

Indexed as

Dietary SupplementsAdultAnthropometryBlood PressureCardiovascular DiseasesCitrusCitrus paradisiDouble-Blind MethodEndothelium, VascularExerciseFemaleFlavanonesFlavonesHealthy VolunteersHeart Disease Risk FactorsHumansFlavanonesFlavonesInflammation MediatorsLipidsPolyphenolsbitter orangecardiovascular riskcitrus flavonoidsendothelial functiongrapefruitolivepolyphenolssecoiridoids

Identifiers

PMID32438719
PMCPMC7284884
OpenAlexW3027240574

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.